Rebecca Panconesi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rebecca Panconesi has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Schlegel
Transplantation Center, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH
1 shared publication - Mauricio Flores Carvalho
Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy
1 shared publication - Paolo Muiesan
Liver unit, Queen Elizabeth Hospital, Birmingham, UK
1 shared publication - Yuri Longatto Boteon
Instituto Israelita de Ensino e Pesquisa Albert Einstein, Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo 05652-900, Brazil.
1 shared publication
Latest Publications
- Open Access
- 12 August 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (16) , 5791
Preventing Tumour Recurrence after Liver Transplantation: The Role of Machine Perfusion
Tumour recurrence is currently a hot topic in liver transplantation. The basic mechanisms are increasingly discussed, and, for example, recurrence of hepatocellular carcinoma is often described in pre-injured donor livers, which frequently suffer from significant ischemia/reperfusion injury. This review article highlights the underlying mechanisms and describes the specific tissue milieu required to promote tumour recurrence after liver transplantation. We summarise the current literature in this field and show risk factors that contribute to a pro-tumour-recurrent environment. Finally, the potential role of new machine perfusion technology is discussed, including the most recent data, which demonstrate a protective effect of hypothermic oxygenated perfusion before liver transplantation.
- 12 August 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (16) , 5791
Open AccessPreventing Tumour Recurrence after Liver Transplantation: The Role of Machine Perfusion
Tumour recurrence is currently a hot topic in liver transplantation. The basic mechanisms are increasingly discussed, and, for example, recurrence of hepatocellular carcinoma is often described in pre-injured donor livers, which frequently suffer from significant ischemia/reperfusion injury. This review article highlights the underlying mechanisms and describes the specific tissue milieu required to promote tumour recurrence after liver transplantation. We summarise the current literature in this field and show risk factors that contribute to a pro-tumour-recurrent environment. Finally, the potential role of new machine perfusion technology is discussed, including the most recent data, which demonstrate a protective effect of hypothermic oxygenated perfusion before liver transplantation.